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ABSTRACT
Papilloma associated with recurrent respiratory papillomatosis (RRP), caused by human papilloma virus (HPV) infection 
types 6 and 11, is the most common benign neoplasm of the larynx. The clinical features of RRP vary widely from mild to 
aggressive forms. RRP in children is known as juvenile-onset recurrent respiratory papillomatosis (JORRP). Its outcome may 
be poor or even fatal due to the high rate of recurrence and eventual spread to the entire respiratory tract. Pulmonary 
invasion is reported to occur in 3.3% of patients with RRP, and malignant transformation in 0.5% of patients. We report 
the case of a 39-year-old female patient with a diagnosis of JORRP from the age of 3 years, with extensive bilateral 
pulmonary involvement and malignant transformation. Analysis of the papilloma and carcinomatous tissues revealed the 
presence of HPV type 11, which is associated with rapid and aggressive progression. We discussed the case on the basis 
of a literature review on pulmonary invasion, malignant transformation, and HPV 11 aggressiveness. 
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CASE REPORT
A 39-year-old Caucasian female had been 
diagnosed with juvenile-onset recurrent respiratory 
papillomatosis (JORRP) at the age of 3 years, and 
several polypoid lesions’ resections were performed at 
follow-up every 3 months from then on. She denied 
smoking and drinking alcoholics. She started 
presenting with shortness of breath and chest pain 
over the last three years, when the diagnosis of 
the pulmonary involvement by the papillomatosis 
was made with the aid of a thoracic computed 
tomography (CT). At her last hospitalization — 6 days 
before her death — she presented to the emergency 
room complaining of worsening of shortness of 
breath, chest pain and weight loss. A new CT scan 
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was performed showing a worsening pattern of the 
pulmonary invasion, and a working diagnosis of 
bronchopneumonia. She was prescribed antibiotics, 
and a transbronchial biopsy was made. Her clinical 
status worsened with progressive respiratory failure 
accompanied by sepsis and death.
AUTOPSY FINDINGS
A post-mortem examination revealed multiple 
polypoid lesions varying from 0.5 to 1.0 cm in diameter 
in the larynx (Figure 1), which was consistent with 
extensive papillomatosis with evident koilocytotic atypia 
(Figure 2).
The trachea and bronchi presented hyperemia, 
and the pleural surfaces were firmly adhered at the 
posterior thoracic wall. The pulmonary parenchyma 
was largely replaced bilaterally by multiple confluent 
nodules measuring between 1.0 and 5.0 cm in 
diameter, some of them with necrotic and/or purulent 
centers (Figure 3). The histological examination 
confirmed the diagnosis of the last in vivo biopsy 
(undertaken 2 days before the patient’s death), of a 
well differentiated squamous cell carcinoma, diffusely 
infiltrating both lungs and extending to the posterior 
thoracic wall (Figure 4).
We tested tissue slices from the different lesions 
by polymerase chain reaction (PCR) followed by 
reverse blot hybridization with the automated 
human papilloma virus (HPV) genotyping using the 
INNO-LiPA HPV Genotyping kit (Fujirebio, USA), in an 
AutoBlot-3000H (MedTec Biolab Equipment, USA).1,2
We were able to detect HPV 11 in the tissue 
derived from both the laryngeal papilloma and the 
carcinomatous lung.
DISCUSSION
Despite the low incidence, papillomas associated 
with HPV infection types 6 and 11 are the most common 
benign neoplasms of the larynx, corresponding to 
84% of cases. They are characterized by numerous 
papillomas, which are generally limited to the larynx.3,4
Figure 1. Gross view of the larynx with multiple polypoid projections in the larynx.
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Figure 2. Photomicrography of the laryngeal papilloma with evident koilocytotic atypia (H&E, 150X).
Figure 3. Gross view of the mediastinal organs showing lungs largely replaced bilaterally by multiple confluent and 
partially necrotic nodules.
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The course  of  the recurrent  resp i ratory 
papillomatosis (RRP) is unpredictable, as some patients 
present a mild form with spontaneous recovery or cure 
after a single exeresis of the laryngeal papilloma, while 
others present an aggressive form of the disease with 
many recurrences requiring multiple interventions and 
hospitalizations.4,5 The latter situation is less common, 
with the incidence rate of 1.8 cases per 100,000 adults 
and 4.3 cases per 100,000 children. A smaller number 
of patients present the malignant transformation of 
the lesion.6
RRP is clinically divided according to the age of 
onset: JORRP is used to describe the disease when 
it primarily manifests in children around the age of 
2 to 4 years, and adult-onset recurrent respiratory 
papillomatosis (AORRP) when it manifests mainly 
between the ages of 20 and 40 years.6 Although 
the lesion is benign in nature, RRP may present an 
aggressive clinical course among children and can be 
fatal because of its repeated recurrence and spread 
throughout the respiratory tract.7
It is believed that JORRP is vertically transmitted 
through the mother’s infected genital tract at the time 
of birth. Indeed, a case-control study of 3033 Danish 
births showed that the risk of JORRP increased 
231 times when the mother had genital warts during 
pregnancy,8 while AORRP is related to urogenital 
dissemination3 and possible re-activation of a latent 
HPV infection acquired in childhood.9
A systematic review carried out in 2008 by 
Gélinas et al.10 found that 83% of cases were 
diagnosed before 4 years of age (median age: 2 years; 
range: 2 months to 19 years). In 2014, Niyibizi et al.11 
analyzed 19 studies concerning the age of the initial 
diagnosis of JORRP, and found the mean age to be 
2-9.4 years, with a median of 3-5.5 years. The results 
of the previous studies suggested that JORRP is not 
only more aggressive than AORRP, but also more 
prone to present a poor clinical course when diagnosed 
before the age of 3 years.9,12 Although our patient was 
diagnosed when she was 3 years old, the disease did 
not follow an aggressive course until her final days.
Figure 4. Photomicrography of the lung showing invasive well differentiated squamous cell carcinoma of the lung 
(H&E, 50X).
Mitsumoto GL, Del Carlo Bernardi F, Paes JF, Villa LL, Mello B, Pozzan G
5-7Autops Case Rep (São Paulo). 2018;8(3):e2018035
The diagnosis is usually made by direct or indirect 
laryngoscopy. The vocal fold is the first and predominant 
site of the papilloma lesions. Bronchoscopy with biopsy 
must be performed to assess and study the full extent 
of the disease. Hoarseness is the main presenting 
symptom and may be accompanied by stridor, which is 
initially inspiratory, but it then becomes biphasic. These 
symptoms may be followed by airway obstruction.7,13
When RRP results in respiratory distress by 
obstructing papil loma, a tracheotomy may be 
necessary. However, it has been suggested that this 
procedure may activate or contribute to the spread of 
the disease to the lower respiratory tract.7 Currently, 
there is no therapy that offers a cure for RRP; 
however, surgical excisions are frequently performed 
to improve the patient’s voice quality and to prevent 
respiratory obstruction.9 With regard to the disease’s 
aggressiveness, Tjon Pian Gi et al.14 showed that 
patients with RRP onset at an early age had a higher 
number of surgical interventions in the first years of 
the disease, which is possibly due to two causes: first, 
RRP is characterized by a more aggressive course at 
the beginning of the disease in this age group; and 
second, at presentation the disease is often already 
widespread and requires more than one intervention.
In studies carried out between 1950 and 1980 
comprising 532 cases, the order of frequency of the 
disease’s propagation was in the true vocal cords, 
the oral cavity, the trachea, the bronchi, and the 
esophagus. In 2%–17% of RRP cases, the propagation 
occurred through to the distal trachea and bronchi, 
and less than 1% to the pulmonary parenchima,6,15-17 
as observed in our case. However, Gélinas et al.10 
brought together cohort studies on RRP, and of 
the 1666 patients with the disease 55 (3.3%) had 
pulmonary involvement. In addition, cross-sectional 
studies were evaluated in the same review, which 
showed an incidence of pulmonary dissemination of 
2.3% (28 of 1202 patients).
Several hypotheses have been proposed to explain 
the development of pulmonary lesions: contiguous 
extension of papilloma, diffuse viral contamination, 
a multicentric origin of papil loma, and aerial 
dissemination. However, the most common reported 
causes of dissemination to the trachea, bronchi, and 
lungs are thought to occur when the tracheostomy 
and endoscopic resection are perfromed10,18 in 
which fragments of the detached lesions are carried 
downwards by the airflow. Fragments that lodge in 
the proximal respiratory bronchioles are removed by 
coughing and via the mucociliary transport system. 
Smaller fragments, which are propelled further out 
in the airway beyond the ciliated epithelium, may be 
poorly cleared, and depending on the host’s defenses 
and the characteristics of the papilloma, they may 
grow.16 Our patient did not receive a tracheostomy 
but did undergo several resections during her lifetime; 
the pulmonary involvement may be explained by the 
multiple resections.
Pulmonary involvement in RRP is twice as 
frequent among males compared with females, 
and is associated with a more aggressive clinical 
course. The median interval time between the 
diagnosis of RRP and the lung involvement is 8 years 
(range <1–45).10 The number of pulmonary lesions 
is directly associated with the symptoms, and when 
the lesions become numerous and large, or progress 
rapidly, the prognosis deteriorates.16,19 The difference 
of disease aggressiveness between juveniles and adults 
disappears after 10 years of follow-up; however, 
this does not apply to distal spread, which is more 
pronounced in juveniles regardless of disease duration.9 
The worse prognosis is characterized by repeated polyp 
excisions, tracheostomy, and ultimately death due to 
respiratory failure or infections.4,19
Malignant transformation to squamous cell 
carcinoma, as found in our case study, is a rare event 
that, according to Gélinas et al.,10 occurs in 0.55% 
(9 in 1666 patients with RRP), and may be found 
in the larynx, the bronchi, or the lungs. Malignant 
transformation into squamous cell carcinoma is more 
frequent in older children, and the median time interval 
between the diagnosis of JORRP and the diagnosis of 
cancer is 19 years (range 4-45 years).10,20 However, 
in patients with RRP and pulmonary involvement, 
cancer developed in 16% (9 of the 55 patients), 
and was predominantly of the squamous cell type. 
These findings suggest that patients with pulmonary 
involvement of JORRP are more prone to develop 
malignant disease than those with isolated upper 
airway involvement.
The HPV may remain quiescent in the mucosa 
for a long time. The malignant transformation may 
occur 25 years after the onset of JORRP, probably as 
Juvenile-onset recurrent respiratory papillomatosis with pulmonary involvement and carcinomatous transformation
6-7 Autops Case Rep (São Paulo). 2018;8(3):e2018035
a consequence of the host genome’s changes induced 
by environmental carcinogens and by interaction with 
the HPV genome. Therefore, a long-term follow-up 
of patients with relapsed JORRP is recommended.4,21 
In our case, the malignancy was diagnosed 33 years 
after the diagnosis of JORRP.
HPV types 6 and 11 are considered low risk for 
the development of pre-cancerous lesions in the 
genital tract; however, patients with RRP may develop 
bronchopulmonary carcinoma when infected by these 
virus types, especially when they are associated with 
any of the following potential cofactors: (i) radiation; 
(ii) immunosuppression; (iii) chemotherapy; (iv) multiple 
recurrences; and (v) smoking and/or alcohol addiction.4 
HPV types 6 and 11 are found in more than 95% 
of JORRP cases; HPV 11 alone in 47% while other 
genotypes, namely 16, 31, 33, 35, and 39, account for 
less than 5%.11 Our patient had multiple recurrences 
as the only cofactor for developing the carcinoma.
It has been reported that patients with JORRP 
infected by HPV 11 experience a more rapid and 
aggressive disease progression than those infected by 
HPV 6. HPV 11 is more associated with squamous cell 
carcinoma, with invasion of the lungs and other sites. 
Patients affected by HPV-11-related papillomatosis 
are younger, have a longer period of disease activity, 
require more surgical procedures, have more laryngeal 
spread, and are less likely to enter remission. These 
data suggest that HPV 11 can play an important role 
in the carcinogenesis of the larynx and the respiratory 
tract, particularly in patients with JORRP.9,10,12,14,22,23
In the study of the final biopsy and the post-mortem 
examination samples of our patient, we found—by 
reverse hybridization and PCR—HPV 11 infected 
lesions. These findings are consistent with those 
encountered in the literature data review.
CONCLUSION
JORRP’s aggressiveness is related to three strong 
risk factors: (i) age at diagnosis; (ii) type 11 HPV; and 
(iii) multiple resections. Ultimately, JORRP can be 
fatal as a result of acute airway obstruction due to 
pulmonary spread or malignant degeneration of the 
papillomatous lesions.
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